glp-1 insulin Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated release and are used to treat type 2 diabetes mellitus and #obesity. receptor agonists and GLP-1 and glucose-dependent insulinotropic JCI Insight - GLP-1 receptor

We are leveraging our size and scale to secure access to one of the highest-quality supplies of compounded GLP-1s available today in order to be a part of easing the strain this shortage is placing on the millions of Americans who have obesity and are looking for help

Local administration is commonly used because its effects appear strongest close to the target tissue

Chika Anekwe, Obesity Medicine Clinical Director at Massachusetts General Hospital Weight Center and instructor at Harvard Medical School, points out that a common misconception is that everyone experiences major side effects

The patient may experience severe headaches, dizziness, and diarrhea